Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Centers for Disease Control and Prevention, Compensation for Damages (Law), Decisions and Verdicts, Drugs (Pharmaceuticals), Gilead Sciences Inc, Health and Human Services Department, Inventions and Patents, Suits and Litigation (Civil)
←Fox Producer Dismisses, for Now, Case Accusing Network of Coercion
How Wall Street Is Preparing for a Debt Ceiling Showdown→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube